Yervoy
Ultimovacsâ cancer vaccine shows survival benefit in BMS combo trial despite missing primary endpoint
Anika Sharma
Ultimovacs, the Norwegian biotech company, has staged a remarkable comeback for its cancer vaccine candidate. Despite encountering a setback earlier ...
Ultimovacs Explores Innovative Approaches to Conclude Phase 2 Cancer Trial Amid Prolonged Anticipation for Survival Data
Anika Sharma
Ultimovacs, a Norwegian biotech company, is grappling with prolonged delays in obtaining midphase melanoma trial data, prompting the company to ...
